Stock screener

VERA

Conviction 8HealthcareScan · Thu, Sep 24, 2026

Vera Therapeutics, Inc. (VERA) closed at $33.34 (+0.86%) on Sep 24, 2026. Price is below its 50-day and below its 200-day moving average. RSI(14) 48, RS Rating 86, -40.1% from its 52-week high, -31.4% year to date. Sector: Healthcare · PHARMACEUTICAL PREPARATIONS.

VERA$33.34+0.86%
ResistanceSupportVol 14Insider sell
63 bars
8
Vol MA14 2.96M
Jun 26Jul 15Aug 3Aug 19Sep 8Sep 24
Vera Therapeutics, Inc.PHARMACEUTICAL PREPARATIONSwww.veratx.com ↗
Price33.34
Change+0.86%
Gap-1.47%
Rel volume0.98×
Avg volume2.69M
Avg $ vol91.59M
SMA 2034.30
SMA 5033.74
SMA 20039.46
Price vs 50-1.21%
Price vs 200-15.52%
MA stackbearish
50/200 cross—
Supertrendup · 30.43
RSI (14)48
MACD hist-0.05
MACD crossbear · 0d
Stoch %K / %D36 / 51
ADX (14)17
+DI / −DI24 / 19
RSI divergence—
MACD divergence—
ATR %6.48%
ADR %5.84%
52w high55.67
52w low24.10
From 52w high-40.12%
Above 52w low+38.32%
New 52w highNo
SqueezeOn · 8d
Bollinger width11.83%
%B0.26
Donchian pos36.05%
Donchian high37.14
Donchian low31.19
AVWAP (52w high)38.15
vs AVWAP high-12.62%
AVWAP (52w low)38.07
vs AVWAP low-12.44%
OBV trendDown
Chaikin MF (20)-0.03
Today vs 20d0.98×
Avg vol (14d)2.96M
Avg vol (20d)2.69M
Avg $ vol (20d)91.59M
Market cap2.4B
RS Rating86 / 99
RS 3m (vs SPY)-22.18%
RS 6m (vs SPY)-33.81%
RS line new highNo
Trend template2/8
Technical rank27.0
1 week-2.73%
1 month-5.51%
3 months-17.69%
6 months-16.99%
1 year+28.41%
YTD-31.44%
P/E-8.02
P/B5.89
P/S—
P/FCF-9.94
EPS-4.66
Div yield—
ROE-73.48%
ROA-56.21%
Debt/Eq0.18
Current10.92
EV/EBITDA-7.71
Gross margin—
Net margin—
Rev growth—
EPS growth-96.92%
Price target75.40
Target upside126.19%
Analyst ratingBuy
Institutional113.29%
Ent. value2.43B
Revenue—
Net income-109.47M
Gross profit—
Free cash flow-241.73M
IndustryPHARMACEUTICAL PREPARATIONS
ExchangeNasdaq
Shares out71.78M
Employees339
ListedFri, May 14, 2021
Free float62.91M
Float %87.7%
Short interest19.87M
Days to cover10.8d
Short volume69.8%
Squeeze score85 / 100
Next earnings—
EPS forecast—
Last EPS vs est−$1.52 vs −$1.60
Last surprise+5.0% beat
Setup gradeD
Conviction8 / 100
Pattern quality—
Tech rank27.0 / 100
Group rank59 / 100
Status laneNo active setup
Setup direction—
Pattern family
Resistance37.05
Support29.20
Days since event—
Candle confirm—

Financials as of Tue, Jun 30, 2026 · quarterly.

Congress activity

Disclosed STOCK Act trades in VERA

All disclosures →
No recent disclosed trades by Congress in VERA. STOCK Act filings can lag the trade by up to 45 days.

Insider activity

SEC Form 4 transactions in VERA · open-market 6 sells

InsiderSideShares
Fordyce Marshall
PRESIDENT AND CEO · Class A Common Stock · 2026-09-15
Exercise18.5K
Fordyce Marshall
PRESIDENT AND CEO · Class A Common Stock · 2026-09-15
Sell18.5K
Fordyce Marshall
PRESIDENT AND CEO · Stock Option (Right to Buy) · 2026-09-15
Exercise18.5K
Fordyce Marshall
PRESIDENT AND CEO · Stock Option (Right to Buy) · 2026-07-07
Exercise46.25K
Fordyce Marshall
PRESIDENT AND CEO · Class A Common Stock · 2026-07-07
Exercise46.25K
Fordyce Marshall
PRESIDENT AND CEO · Class A Common Stock · 2026-07-07
Sell1K
Fordyce Marshall
PRESIDENT AND CEO · Class A Common Stock · 2026-07-07
Sell32.55K
Fordyce Marshall
PRESIDENT AND CEO · Class A Common Stock · 2026-07-07
Sell10.5K
Fordyce Marshall
PRESIDENT AND CEO · Class A Common Stock · 2026-07-07
Sell2.2K
Fordyce Marshall
PRESIDENT AND CEO · Class A Common Stock · 2026-06-23
Sell88

SEC filings

EDGAR filings in VERA · 10 recent

EDGAR →

Get daily signals & real-time alerts.

StockSetups scans ~12,300 US stocks & ETFs after every close and sorts every long setup into four ranked lanes — each with a trade plan — plus an always-on engine firing 35+ real-time intraday alerts. Free for 14 days, cancel in one click.

Start free — 14-day full access →

Educational data, not financial advice. Patterns, levels and the trade plan are algorithmic, not a recommendation to trade.